Relaunching Coverage of Quintiles IMS: Post-Merger Valuation at $90; Shares Undervalued
We are relaunching coverage of Quintiles IMS and updating our position on the company to account for the merger between Quintiles, the largest contract research organization, and IMS Health, the dominant player in the healthcare data and analytics space. We believe the combined entity’s leading positions in the late-stage contract research, development, and drug commercialization markets make it the go-to partner for biotech and pharma clients and support the firm’s upgrade to wide moat and stab...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.